We are live on
!
Find out more
GTC
Ghost Tree Capital Portfolio holdings
AUM
$331M
1-Year Est. Return
70.11%
This Fund
S&P 500
This Quarter
Est. Return
+6.99%
1 Year Est. Return
+70.11%
3 Year Est. Return
+265.05%
5 Year Est. Return
+3,034.98%
10 Year Est. Return
+22,104.75%
AUM
$184M
AUM Growth
+$42.5M
(+30%)
Cap. Flow
+$36.1M
Cap. Flow
% of AUM
19.61%
Top 10 Holdings %
Top 10 Hldgs %
31.33%
Holding
99
New
45
Increased
12
Reduced
8
Closed
29
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
+$5.07M |
| 2 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$4.94M |
| 3 |
CYBX
CYBERONICS INC
CYBX
|
+$4.32M |
| 4 |
AGN
Allergan Inc
AGN
|
+$4.15M |
| 5 |
ARIA
Ariad Pharmaceuticals Inc
ARIA
|
+$4.09M |
Top Sells
| 1 |
MDVN
MEDIVATION, INC.
MDVN
|
+$6.17M |
| 2 |
Cooper Companies
COO
|
+$5.42M |
| 3 |
Teva Pharmaceuticals
TEVA
|
+$5.24M |
| 4 |
Boston Scientific
BSX
|
+$5.11M |
| 5 |
Insmed
INSM
|
+$4M |
Sector Composition
| 1 | Healthcare | 63.11% |
| 2 | Technology | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
CALL
Bristol-Myers Squibb
BMY
$124B
| $10.2M | 5.56% |
+200,000
| New | +$9.99M |
|
2
CALL
Bausch Health
BHC
$1.8B
| $6.56M | 3.56% |
+50,000
| New | +$5.96M |
|
3
CALL
AbbVie
ABBV
$450B
| $5.78M | 3.14% |
+100,000
| New | +$5.55M |
|
4
CALL
Agilent Technologies
A
$37.1B
| $5.7M | 3.09% |
+139,800
| New | +$5.71M |
|
5
Community Health Systems
CYH
$465M
| $5.48M | 2.97% |
121,000
| – | – |
|
|
HZNP
6
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $5.22M | 2.83% |
+425,000
| New | +$4.94M |
|
|
7
Zimmer Biomet
ZBH
$17.6B
| $5.03M | 2.73% |
+51,500
| New | +$5.07M |
|
|
TRNX
8
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $4.78M | 2.59% |
200,000
+80,000
| +67% | +$1.79M |
|
9
Vertex Pharmaceuticals
VRTX
$123B
| $4.49M | 2.44% |
+40,000
| New | +$3.81M |
|
|
AGN
10
DELISTED
Allergan Inc
AGN
| $4.46M | 2.42% |
+25,000
| New | +$4.15M |
|
|
CPHD
11
CALL
DELISTED
Cepheid Inc
CPHD
| $4.4M | 2.39% |
+100,000
| New | +$4.22M |
|
12
HCA Healthcare
HCA
$82.3B
| $4.23M | 2.3% |
60,000
+15,000
| +33% | +$991K |
|
|
MNK
13
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $4.06M | 2.2% |
+45,000
| New | +$3.52M |
|
|
ZLTQ
14
DELISTED
ZELTIQ Aesthetics, Inc.
ZLTQ
| $3.96M | 2.15% |
+175,000
| New | +$3.46M |
|
15
Intuitive Surgical
ISRG
$122B
| $3.92M | 2.13% |
+76,500
| New | +$3.8M |
|
|
CYBX
16
DELISTED
CYBERONICS INC
CYBX
| $3.84M | 2.08% |
+75,000
| New | +$4.32M |
|
|
ARIA
17
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $3.78M | 2.05% |
+700,000
| New | +$4.09M |
|
|
THOR
18
DELISTED
THORATEC CORPORATION
THOR
| $3.74M | 2.03% |
+140,000
| New | +$3.98M |
|
19
AtriCure
ATRC
$1.77B
| $3.68M | 2% |
250,000
+25,000
| +11% | +$398K |
|
|
AGN
20
DELISTED
Allergan plc
AGN
| $3.62M | 1.96% |
15,000
-15,000
| -50% | -$3.36M |
|
|
CNCE
21
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $3.54M | 1.92% |
+280,966
| New | +$2.73M |
|
22
TherapeuticsMD
TXMD
$23.8M
| $3.48M | 1.89% |
15,000
+10,000
| +200% | +$2.52M |
|
|
EVHC
23
DELISTED
Envision Healthcare Holdings Inc
EVHC
| $3.47M | 1.88% |
+33,400
| New | +$3.54M |
|
|
ZSPH
24
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $3.33M | 1.81% |
+85,000
| New | +$2.81M |
|
|
25
Bausch Health
BHC
$1.8B
| $3.28M | 1.78% |
+25,000
| New | +$2.98M |
|
Similar funds
SF
AFS
SFA
E
OHCM
MC
BRA
S
Ghost Tree Capital's Q3 2014 Portfolio in Review
As of Q3 2014, Ghost Tree Capital held 99 positions worth $184M, up 30% from $142M the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ghost Tree Capital deployed $36.1M of net new capital in Q3 2014, opening 45 new positions and adding to 12 existing holdings. Its largest new stake was Zimmer Biomet: 51,500 shares worth $5.03M.
By sector, the portfolio is most concentrated in Healthcare at 63% of assets, up from 60% a quarter earlier, followed by Technology.
On the sell side, the largest reduction was Allergan plc, an estimated $3.36M trimmed.
- Ghost Tree Capital's largest Q3 2014 buy was Zimmer Biomet: 51,500 shares worth $5.03M.
- Ghost Tree Capital added most to TherapeuticsMD in Q3 2014, an estimated $2.52M increase.
- Ghost Tree Capital's biggest Q3 2014 reduction was Allergan plc, cutting an estimated $3.36M.
- Ghost Tree Capital fully exited MEDIVATION, INC. in Q3 2014, selling an estimated $6.17M.
- Ghost Tree Capital's ten largest holdings make up 31% of its $184M portfolio in Q3 2014.
- Ghost Tree Capital opened 45 new positions and closed 29 in Q3 2014.
- Ghost Tree Capital's portfolio value rose 30% quarter-over-quarter to $184M.
Based on Ghost Tree Capital's 13F filing for Q3 2014, filed 14 Nov 2014.